Study Summary
The purpose of this study is to evaluate the safety and efficiency of CD19-Targeted CAR-T in Treating Patients with relapsed/refractory acute leukemia.
Interested in this trial?
Submit an InquiryInterventions
CART-19 cellsBIOLOGICAL
CD19-Targeted CAR-T cells are infused to patient received FC chemotherapy
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| 307 Hospital of PLA | Beijing | Beijing 100071 | China |